Clinical Trial Update: Trial to Evaluate Efficacy and Safety of Bortezomib in Patients With Severe Autoimmune Encephalitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy and safety of bortezomib in patients with severe autoimmune encephalitis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: Jena University Hospital | Conditions: Autoimmune Encephalitis | Phase 2 | Status: RECRUITING